| Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry … R Shouval, JA Fein, M Labopin, N Kröger, RF Duarte, P Bader, ... The Lancet Haematology 6 (11), e573-e584, 2019 | 203 | 2019 |
| Impact of latency duration on the prognosis of preterm infants after preterm premature rupture of membranes at 24 to 32 weeks' gestation: a national population-based cohort study E Lorthe, PY Ancel, H Torchin, M Kaminski, B Langer, D Subtil, ... The Journal of pediatrics 182, 47-52. e2, 2017 | 112 | 2017 |
| Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT J Sanz, JE Galimard, M Labopin, B Afanasyev, E Angelucci, F Ciceri, ... Journal of hematology & oncology 13, 1-13, 2020 | 97 | 2020 |
| A multiple imputation approach for MNAR mechanisms compatible with Heckman's model JE Galimard, S Chevret, C Protopopescu, M Resche‐Rigon Statistics in medicine 35 (17), 2907-2920, 2016 | 87 | 2016 |
| Heckman imputation models for binary or continuous MNAR outcomes and MAR predictors JE Galimard, S Chevret, E Curis, M Resche-Rigon BMC medical research methodology 18, 1-13, 2018 | 82 | 2018 |
| Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria C Gurnari, S Pagliuca, PH Prata, JE Galimard, LFB Catto, L Larcher, ... Journal of Clinical Oncology 41 (1), 132-142, 2023 | 61 | 2023 |
| Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study AM Willasch, C Peters, P Sedláček, JH Dalle, V Kitra-Roussou, ... Bone marrow transplantation 55 (8), 1540-1551, 2020 | 59 | 2020 |
| Management of upper gastrointestinal bleeding in emergency departments, from bleeding symptoms to diagnosis: a prospective, multicenter, observational study PC Thiebaud, Y Yordanov, JE Galimard, PA Raynal, S Beaune, L Jacquin, ... Scandinavian journal of trauma, resuscitation and emergency medicine 25, 1-9, 2017 | 41 | 2017 |
| Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia … J Sanz, JE Galimard, M Labopin, B Afanasyev, MI Sergeevich, ... Journal of Hematology & Oncology 14 (1), 84, 2021 | 39 | 2021 |
| Outcomes of unmanipulated haploidentical transplantation using post-transplant cyclophosphamide (PT-Cy) in pediatric patients with acute lymphoblastic leukemia A Ruggeri, JE Galimard, O Paina, F Fagioli, A Tbakhi, A Yesilipek, ... Transplantation and Cellular Therapy 27 (5), 424. e1-424. e9, 2021 | 37 | 2021 |
| Post-transplant cyclophosphamide in one-antigen mismatched unrelated donor transplantation versus haploidentical transplantation in acute myeloid leukemia: a study from the … G Battipaglia, JE Galimard, M Labopin, AM Raiola, D Blaise, A Ruggeri, ... Bone marrow transplantation 57 (4), 562-571, 2022 | 35 | 2022 |
| Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood … R Shouval, JA Fein, M Labopin, C Cho, A Bazarbachi, F Baron, G Bug, ... The Lancet Haematology 8 (3), e205-e215, 2021 | 32 | 2021 |
| Longitudinal outcome over two decades of unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: an ALWP/EBMT analysis A Nagler, M Ngoya, JE Galimard, M Labopin, M Bornhäuser, M Stelljes, ... Clinical Cancer Research 28 (19), 4258-4266, 2022 | 30 | 2022 |
| Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study T Longval, JE Galimard, AC Leprêtre, F Suarez, D Amiranoff, M Cazaux, ... British Journal of Haematology 193 (4), 814-826, 2021 | 30 | 2021 |
| Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin F Baron, JE Galimard, M Labopin, I Yakoub-Agha, R Niittyvuopio, ... haematologica 105 (4), 1138, 2019 | 29 | 2019 |
| The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing J de la Fuente, E Gluckman, J Makani, P Telfer, L Faulkner, S Corbacioglu, ... The Lancet Haematology 7 (12), e902-e911, 2020 | 23 | 2020 |
| Busulfan–fludarabine-or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major R Lüftinger, N Zubarovskaya, JE Galimard, A Cseh, E Salzer, F Locatelli, ... Annals of Hematology, 1-11, 2022 | 21 | 2022 |
| Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myelogenous leukemia: a study … A Ruggeri, JE Galimard, M Labopin, H Rafii, D Blaise, F Ciceri, ... Transplantation and Cellular Therapy 28 (10), 710. e1-710. e10, 2022 | 19 | 2022 |
| Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients C Bigenwald, JE Galimard, L Quero, A Cabannes-Hamy, C Thieblemont, ... Oncotarget 8 (45), 80073, 2017 | 17 | 2017 |
| Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid … R Devillier, JE Galimard, M Labopin, D Blaise, AM Raiola, J Pavlu, ... Bone Marrow Transplantation 57 (9), 1421-1427, 2022 | 16 | 2022 |
